Your browser doesn't support javascript.
loading
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial.
Moro-Sibilot, D; Cozic, N; Pérol, M; Mazières, J; Otto, J; Souquet, P J; Bahleda, R; Wislez, M; Zalcman, G; Guibert, S D; Barlési, F; Mennecier, B; Monnet, I; Sabatier, R; Bota, S; Dubos, C; Verriele, V; Haddad, V; Ferretti, G; Cortot, A; De Fraipont, F; Jimenez, M; Hoog-Labouret, N; Vassal, G.
Affiliation
  • Moro-Sibilot D; Thoracic Oncology Unit, Grenoble-Alpes University Hospital, Grenoble; Intergroupe Francophone de Cancérologie Thoracique (IFCT), Paris. Electronic address: DMoro.pneumo@chu-grenoble.fr.
  • Cozic N; Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, INSERM U1018, ESP, Paris-Saclay and Paris-Sud Universities, Villejuif.
  • Pérol M; Department of Medical Oncology, Léon Bérard Cancer Centre, Lyon.
  • Mazières J; Pneumology Department, Toulouse University Hospital and Paul Sabatier University, Toulouse.
  • Otto J; Department of Medicine, Antoine Lacassagne Cancer Centre, Nice.
  • Souquet PJ; Department of Pneumology and Thoracic Oncology, Lyon Sud Hospital Center, Hospices Civils de Lyon, Pierre Bénite.
  • Bahleda R; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif.
  • Wislez M; Pneumology Department, Tenon Hospital, AP-HP and "Pierre and Marie Curie" University, Paris.
  • Zalcman G; Thoracic Oncology Department-CIC INSERM 1425, Bichat University Hospital, AP-HP, Paris; Paris-Diderot University, Paris.
  • Guibert SD; Hematology Department, Pontchaillou, Rennes.
  • Barlési F; Multidisciplinary Oncology & Therapeutic Innovations Department, APHM and Aix Marseille University, INSERM, CNRS, CRCM, Marseille.
  • Mennecier B; Pneumology Department, Strasbourg University Hospital, Strasbourg.
  • Monnet I; Pneumology Department, CHIC Creteil, Créteil.
  • Sabatier R; Department of Medical Oncology, Inserm 1068, CNRS UMR7258, CRCM, Paoli-Calmettes Institute and Aix-Marseille University, Marseille.
  • Bota S; Pneumology Department, Charles Nicolle Hospital, Rouen University Hospital, Rouen.
  • Dubos C; Pneumology Department, François Baclesse Cancer Centre, Caen.
  • Verriele V; Anatomy and Pathological Cytologies Department, Paul Papin Cancer Centre, ICO, Angers.
  • Haddad V; Department of Tumour Biology, Léon Bérard Cancer Centre, Lyon.
  • Ferretti G; Radiology and Medical Imaging Department, Grenoble-Alpes University Hospital, Grenoble.
  • Cortot A; Department of Thoracic Oncology, Lille University Hospital and University of Lille, Lille.
  • De Fraipont F; Molecular Genetic Unit: Hereditary Diseases and Oncology, Grenoble-Alpes University Hospital, Grenoble.
  • Jimenez M; Research and Development UNICANCER, Paris.
  • Hoog-Labouret N; French National Cancer Institute, Boulogne-Billancourt.
  • Vassal G; Clinical Research Division, Gustave Roussy Cancer Campus, Villejuif, France.
Ann Oncol ; 30(12): 1985-1991, 2019 12 01.
Article in En | MEDLINE | ID: mdl-31584608
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Proto-Oncogene Proteins / Carcinoma, Non-Small-Cell Lung / Proto-Oncogene Proteins c-met / Crizotinib Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Proto-Oncogene Proteins / Carcinoma, Non-Small-Cell Lung / Proto-Oncogene Proteins c-met / Crizotinib Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2019 Document type: Article